Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 19, 2013BloodOpen Access

A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models

View Full Paper
Ask AI
Bookmark
Share

Authors

HSHenning R. StennickeLa Jolla Institute for ImmunologyMKMarianne KjalkeNovo Nordisk (Denmark)DKDitte M. KarpfUniversity of North Carolina at Chapel Hill

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Stennicke et al. (2013) studied this question.

synapsesocial.com/papers/6a1e8bc440bc8a3dd7690d0ehttps://doi.org/10.1182/blood-2012-01-407494
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cloning, expression and characterization of a sialidase gene from <i>Arthrobacter ureafaciens</i>2005 · 18 citations
  2. 2GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli2006 · 173 citations
  3. 3Pharmacokinetics and pharmacodynamics of a new recombinant FVIII (N8) in haemophilia A mice2011 · 35 citations
  4. 4Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor–related protein deficiency2003 · 118 citations